BRPI0509678A - partìculas de um meio viscoelástico, método para produzir partìculas de gel injetáveis de um meio viscoelástico, implante para aumento do tecido macio, método para aumento do tecido macio em mamìfero, partìculas de gel injetáveis, e, uso de partìculas de gel injetáveis de um meio viscoelástico - Google Patents

partìculas de um meio viscoelástico, método para produzir partìculas de gel injetáveis de um meio viscoelástico, implante para aumento do tecido macio, método para aumento do tecido macio em mamìfero, partìculas de gel injetáveis, e, uso de partìculas de gel injetáveis de um meio viscoelástico

Info

Publication number
BRPI0509678A
BRPI0509678A BRPI0509678-2A BRPI0509678A BRPI0509678A BR PI0509678 A BRPI0509678 A BR PI0509678A BR PI0509678 A BRPI0509678 A BR PI0509678A BR PI0509678 A BRPI0509678 A BR PI0509678A
Authority
BR
Brazil
Prior art keywords
soft tissue
particles
viscoelastic
injectable gel
gel particles
Prior art date
Application number
BRPI0509678-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Bengt Agerup
Original Assignee
Q Med Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34964714&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0509678(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Q Med Ab filed Critical Q Med Ab
Publication of BRPI0509678A publication Critical patent/BRPI0509678A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/52—Water-repellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0509678-2A 2004-04-08 2005-04-07 partìculas de um meio viscoelástico, método para produzir partìculas de gel injetáveis de um meio viscoelástico, implante para aumento do tecido macio, método para aumento do tecido macio em mamìfero, partìculas de gel injetáveis, e, uso de partìculas de gel injetáveis de um meio viscoelástico BRPI0509678A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56025804P 2004-04-08 2004-04-08
PCT/SE2005/000504 WO2005097218A2 (en) 2004-04-08 2005-04-07 Particles for soft tissue augmentation

Publications (1)

Publication Number Publication Date
BRPI0509678A true BRPI0509678A (pt) 2007-10-09

Family

ID=34964714

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509678-2A BRPI0509678A (pt) 2004-04-08 2005-04-07 partìculas de um meio viscoelástico, método para produzir partìculas de gel injetáveis de um meio viscoelástico, implante para aumento do tecido macio, método para aumento do tecido macio em mamìfero, partìculas de gel injetáveis, e, uso de partìculas de gel injetáveis de um meio viscoelástico

Country Status (12)

Country Link
US (5) US20050226936A1 (https=)
EP (1) EP1734894B2 (https=)
JP (2) JP5074182B2 (https=)
KR (1) KR101236363B1 (https=)
CN (2) CN101897993A (https=)
AU (1) AU2005231674B2 (https=)
BR (1) BRPI0509678A (https=)
CA (1) CA2561685C (https=)
ES (1) ES2599329T3 (https=)
MX (1) MXPA06011386A (https=)
RU (1) RU2363496C2 (https=)
WO (1) WO2005097218A2 (https=)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338433B2 (en) 2002-08-13 2008-03-04 Allergan, Inc. Remotely adjustable gastric banding method
ES2617452T3 (es) 2002-08-28 2017-06-19 Apollo Endosurgery, Inc Dispositivo de banda gástrica resistente a la fatiga
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
WO2005087147A1 (en) 2004-03-08 2005-09-22 Endoart S.A. Closure system for tubular organs
AU2004317849B2 (en) 2004-03-18 2011-03-31 Allergan, Inc. Apparatus and method for volume adjustment of intragastric balloons
US20050226936A1 (en) 2004-04-08 2005-10-13 Q-Med Ab Method of soft tissue augmentation
US8251888B2 (en) 2005-04-13 2012-08-28 Mitchell Steven Roslin Artificial gastric valve
US8043206B2 (en) 2006-01-04 2011-10-25 Allergan, Inc. Self-regulating gastric band with pressure data processing
US7798954B2 (en) 2006-01-04 2010-09-21 Allergan, Inc. Hydraulic gastric band with collapsible reservoir
KR100820151B1 (ko) 2007-02-20 2008-04-08 엘지전자 주식회사 덕트리스 건조기
US20080293637A1 (en) 2007-05-23 2008-11-27 Allergan, Inc. Cross-linked collagen and uses thereof
US7942930B2 (en) 2007-06-15 2011-05-17 Q-Med Ab Biocompatible implant system and method
FR2918377B1 (fr) 2007-07-05 2010-10-08 Estelle Piron Gel co-reticule de polysaccharides
US8318695B2 (en) 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
WO2009044403A2 (en) * 2007-10-05 2009-04-09 Juvenis Ltd. Injectable biodegradable polymer compositions for soft tissue repair and augmentation
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
JP5670196B2 (ja) 2007-11-16 2015-02-18 バイセプト セラピューティクス、インク． 紫斑を治療する組成物および方法
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
WO2009079555A2 (en) 2007-12-17 2009-06-25 Anna Love Soft tissue filler
CN101502675B (zh) * 2008-02-04 2013-02-13 山东省药学科学院 一种注射用含大分子水凝胶的透明质酸或其盐的混悬液及其制备方法
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
ES2658609T3 (es) 2008-09-02 2018-03-12 Tautona Group Lp Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos, y usos de los mismos
CN101366978B (zh) * 2008-09-03 2013-06-05 陕西瑞盛生物科技有限公司 可注射用的微粒组织充填材料及其制备方法
EP2362762A1 (en) 2008-10-06 2011-09-07 Allergan Medical Sàrl Mechanical gastric band with cushions
US20100185049A1 (en) 2008-10-22 2010-07-22 Allergan, Inc. Dome and screw valves for remotely adjustable gastric banding systems
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US8758221B2 (en) 2010-02-24 2014-06-24 Apollo Endosurgery, Inc. Source reservoir with potential energy for remotely adjustable gastric banding system
US8840541B2 (en) 2010-02-25 2014-09-23 Apollo Endosurgery, Inc. Pressure sensing gastric banding system
KR101764451B1 (ko) 2010-03-12 2017-08-02 알러간 인더스트리 에스에이에스 피부 상태 개선을 위한 히알루론안 폴리머 및 만니톨을 포함하는 유체 조성물
EP3078388B1 (en) 2010-03-22 2019-02-20 Allergan, Inc. Cross-linked hydrogels for soft tissue augmentation
US20110270024A1 (en) 2010-04-29 2011-11-03 Allergan, Inc. Self-adjusting gastric band having various compliant components
US9028394B2 (en) 2010-04-29 2015-05-12 Apollo Endosurgery, Inc. Self-adjusting mechanical gastric band
US20110270025A1 (en) 2010-04-30 2011-11-03 Allergan, Inc. Remotely powered remotely adjustable gastric band system
US8517915B2 (en) 2010-06-10 2013-08-27 Allergan, Inc. Remotely adjustable gastric banding system
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US20120059216A1 (en) 2010-09-07 2012-03-08 Allergan, Inc. Remotely adjustable gastric banding system
US8961393B2 (en) 2010-11-15 2015-02-24 Apollo Endosurgery, Inc. Gastric band devices and drive systems
FR2968305B1 (fr) * 2010-12-06 2014-02-28 Teoxane Procede de preparation d'un gel reticule
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
KR102238406B1 (ko) 2011-06-03 2021-04-08 알러간 인더스트리 에스에이에스 항산화제를 포함하는 피부 충전제 조성물
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US8876694B2 (en) 2011-12-07 2014-11-04 Apollo Endosurgery, Inc. Tube connector with a guiding tip
KR20210071106A (ko) * 2011-12-08 2021-06-15 알러간 인더스트리 에스에이에스 진피 필러 조성물
US8961394B2 (en) 2011-12-20 2015-02-24 Apollo Endosurgery, Inc. Self-sealing fluid joint for use with a gastric band
EP2827914B1 (en) * 2012-03-22 2019-05-08 TRB Chemedica International S.A. Method for repair of ligament or tendon
BR112014031412B1 (pt) * 2012-06-15 2021-01-05 Merz Pharma Gmbh & Co. Kgaa método de preparação de uma composição
US9907740B2 (en) * 2013-01-17 2018-03-06 Jeffrey Hagel Increasing muscular volume in a human using hyaluronic acid
WO2015112907A1 (en) * 2014-01-27 2015-07-30 Allergan Holdings France S.A.S. Spherical forms of cross-linked hyaluronic acid and methods of use thereof
US9164280B1 (en) * 2014-06-25 2015-10-20 Topray Mems Inc. Dust-proof assembly for lens driving device
EP3200838B1 (en) 2014-09-30 2019-09-18 Allergan Industrie, SAS Stable hydrogel compositions including additives
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
HUE047971T2 (hu) 2015-02-13 2020-05-28 Allergan Ind Sas Az arcelemek - például az áll - formázására, megnagyobbítására vagy korrekciójára szolgáló implantátumok
US9737395B2 (en) 2015-06-26 2017-08-22 Phi Nguyen Systems and methods for reducing scarring
DE102015009271A1 (de) * 2015-07-19 2017-01-19 Tracey Lennemann Neue Verwendung von Hyaluronsäure
EP3328351A1 (en) * 2015-07-27 2018-06-06 Galderma S.A. A process for efficient cross-linking of hyaluronic acid
RU2601918C2 (ru) * 2015-08-25 2016-11-10 Частное учреждение образовательная организация высшего образования "Медицинский университет "Реавиз" Способ увеличения объема мягких тканей с использованием свободного соединительнотканного аутотрансплантата при установке формирователей десны на дентальные имплантаты
CA2961868A1 (en) * 2016-04-08 2017-10-08 Johnson & Johnson Consumer Inc. Topical compositions containing cross-linked glycosaminoglycans
RU2638711C1 (ru) * 2016-12-14 2017-12-15 Частное учреждение образовательная организация высшего образования "Медицинский университет "Реавиз" Способ восстановления десневого сосочка при установке формирователей десны на дентальные имплантаты
RU2691538C1 (ru) * 2018-04-13 2019-06-14 Частное учреждение образовательная организация высшего образования "Медицинский университет "Реавиз" Способ пластики мягких тканей в области адентии при одномоментной установке дентального имплантата и постоянного индивидуального абатмента в условиях толстого биотипа десны
EP3787702B1 (en) 2018-05-03 2024-08-07 CollPlant Ltd. Dermal fillers and applications thereof
RU2691566C1 (ru) * 2018-09-24 2019-06-14 Частное учреждение образовательная организация высшего образования "Медицинский университет "Реавиз" Способ устранения недостаточности мягких тканей вокруг установленного имплантата на верхней челюсти
CN113226388B (zh) 2018-12-21 2023-07-25 株式会社Lg化学 具有优异的填充性能的包含透明质酸水凝胶的填充剂
JP2022530895A (ja) * 2019-05-03 2022-07-04 パレット ライフ サイエンシーズ，インク． 改善された組織スペーサー
AR128245A1 (es) 2022-01-11 2024-04-10 Gpq S R L Nuevos derivados de ácido hialurónico como rellenos innovadores

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US402031A (en) * 1889-04-23 Scarf-protector
JPS60502087A (ja) * 1983-08-31 1985-12-05 キングストン・テクノロジーズ・インコーポレーテッド 注入可能な、生理学的に受容できるポリマ−組成物
SE442820B (sv) 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4657548A (en) * 1984-09-11 1987-04-14 Helitrex, Inc. Delivery system for implantation of fine particles in surgical procedures
US4642117A (en) 1985-03-22 1987-02-10 Collagen Corporation Mechanically sheared collagen implant material and method
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
US4969901A (en) * 1988-06-28 1990-11-13 Binder William J Plastic surgery implant
US5007940A (en) * 1989-06-09 1991-04-16 American Medical Systems, Inc. Injectable polymeric bodies
US5246698A (en) * 1990-07-09 1993-09-21 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US6537574B1 (en) * 1992-02-11 2003-03-25 Bioform, Inc. Soft tissue augmentation material
IT1260148B (it) * 1992-04-17 1996-03-28 Fidia Spa Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo
JP3107726B2 (ja) 1994-05-13 2000-11-13 株式会社クラレ 水膨潤性高分子ゲル
US5658592A (en) 1994-05-13 1997-08-19 Kuraray Co., Ltd. Medical crosslinked polymer gel of carboxylic polysaccharide and diaminoalkane
US5451406A (en) * 1994-07-14 1995-09-19 Advanced Uroscience, Inc. Tissue injectable composition and method of use
UA10911C2 (uk) * 1994-08-10 1996-12-25 Мале Впроваджувальне Підприємство "Іhтерфалл" Біосумісhий гідрогель
ES2161825T3 (es) * 1995-03-07 2001-12-16 Ethicon Inc Medio para aumentar la funcion del esfinter de expansion controlada.
US5827937A (en) * 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
IT1288290B1 (it) * 1996-06-21 1998-09-11 Fidia Spa In Amministrazione S Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6063061A (en) * 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
BG102375A (en) * 1997-08-26 1999-11-30 Пегас Оод Inoculation biocompatible hydrophilic gel, method for its preparation and application
JP2000239147A (ja) * 1999-02-18 2000-09-05 Naris Cosmetics Co Ltd 化粧料
US6277392B1 (en) * 1999-09-16 2001-08-21 Carbon Medical Technologies, Inc. Tissue injectable composition
US6436424B1 (en) * 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
WO2002011696A2 (en) * 2000-08-08 2002-02-14 Ev & M Active tissue augmentation materials and method
US6679012B1 (en) 2002-06-26 2004-01-20 Ching-Shyang Chen Earthquake energy eliminator
NZ538266A (en) 2002-08-16 2007-05-31 Denki Kagaku Kogyo Kk Separate type medical material
JP2004181121A (ja) * 2002-12-06 2004-07-02 Denki Kagaku Kogyo Kk 軟骨組織再生用注入剤組成物
FR2850282B1 (fr) * 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
EP1610674A4 (en) * 2003-03-13 2008-05-21 Cheryl M Burgess METHODS OF ADMINISTERING MATERIAL TO PATIENT TO OBTAIN DERMAL IMPROVEMENT
SE526878C2 (sv) * 2003-06-18 2005-11-15 Q Med Ab Medicinsk pump
US8124120B2 (en) * 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
US20050226936A1 (en) 2004-04-08 2005-10-13 Q-Med Ab Method of soft tissue augmentation
US7942930B2 (en) 2007-06-15 2011-05-17 Q-Med Ab Biocompatible implant system and method
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine

Also Published As

Publication number Publication date
KR20070017172A (ko) 2007-02-08
AU2005231674A1 (en) 2005-10-20
WO2005097218A2 (en) 2005-10-20
RU2006139141A (ru) 2008-05-20
JP2007532173A (ja) 2007-11-15
US20050226936A1 (en) 2005-10-13
JP5074182B2 (ja) 2012-11-14
US20140147479A1 (en) 2014-05-29
JP2012179467A (ja) 2012-09-20
CN1950039B (zh) 2010-05-05
EP1734894B1 (en) 2016-08-03
AU2005231674B2 (en) 2010-09-09
CA2561685A1 (en) 2005-10-20
CA2561685C (en) 2013-03-12
CN101897993A (zh) 2010-12-01
EP1734894A2 (en) 2006-12-27
EP1734894B2 (en) 2023-05-17
US20230211051A1 (en) 2023-07-06
ES2599329T3 (es) 2017-02-01
US20200030494A1 (en) 2020-01-30
US11458226B2 (en) 2022-10-04
US20180093017A1 (en) 2018-04-05
MXPA06011386A (es) 2006-12-20
CN1950039A (zh) 2007-04-18
KR101236363B1 (ko) 2013-02-22
RU2363496C2 (ru) 2009-08-10
US11992580B2 (en) 2024-05-28
WO2005097218A3 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
BRPI0509678A (pt) partìculas de um meio viscoelástico, método para produzir partìculas de gel injetáveis de um meio viscoelástico, implante para aumento do tecido macio, método para aumento do tecido macio em mamìfero, partìculas de gel injetáveis, e, uso de partìculas de gel injetáveis de um meio viscoelástico
BRPI0413728B8 (pt) muteína da lipocalina da lágrima humana, métodos para geração e para produção de muteína, composição farmacêutica e uso de muteína
EA200702433A1 (ru) Набухающий в воде гибридный материал с неорганическими добавками и способ его получения
BRPI0818183A2 (pt) reparo e regeneração do tecido renal usando células derivadas do tecido do cordão umbilical humano
EA201000542A1 (ru) Способы, устройства, системы, комплекты и наборы для отведения тканей в ротовой полости
IL178877A0 (en) Activatable particles, preparations and uses
NO20056048L (no) Pan-Kirk2dl nk-receptor antibodies and their use in diagnostik and therapy
DE60238416D1 (de) Plasmaprotein-matritzes und verfahren zu ihrer herstellung
DE602004030254D1 (de) Scaffoldfreies, selbstorganisiertes, 3 dimensionales, synthetisches gewebe
ATE444759T1 (de) Verfahren zur herstellung eines knochenzements
BRPI0518101A (pt) métodos de produção e sìntese de composições nanoparticuladas, composições obtidas e seu uso
ATE485304T1 (de) Muteine von tearlipocalin und verfahren zu deren gewinnung
BRPI0407633A (pt) métodos para gerar um dente primórdio usando células da medula óssea e para gerar uma célula progenitora de dente, célula progenitora de dente, dente primórdio, método para substituir um dente em um paciente em necessidade de substituição de dente, e, usos de um dente primórdio e de uma célula da medula óssea
BRPI0414789A (pt) microgéis em meios orgánicos reticuláveis
RU2009119717A (ru) Водные фармацевтические суспензии, содержащие ребамипид, и способ их получения
DK1715900T3 (da) Kompositstrukturer, som indeholder hyaluronsyre derivaterne deraf som nye knoglesubstitutter og -transplantater
AU2005221582A8 (en) Tissue repair with multipotent cells
BRPI0417672A (pt) processos para produzir composições de vìrus estáveis em armazenamento, composições de vìrus e imunogênicas
BRPI0607883A2 (pt) método para obter material celular prontamente disponìvel derivado de sangue periférico e uma composição do referido material celular
BR0312365A (pt) Meio de cultura autólogo de células-mães progenitoras autólogas humanas, métodos para a preparação do mesmo e de uma composição de células-mães progenitoras autólogas humanas e para a obtenção de células-mães progenitoras musculares autólogas humanas, emprego de um meio de cultura autólogo de células-mães progenitoras autólogas humanas, procedimento para a obtenção de células-mães progenitoras musculares autólogas humanas e procedimento terapêutico de cardiomioplastia celular autóloga, composição enriquecida com células-mães progenitoras musculares autólogas humanas e composição farmacêutica
WO2003052084A3 (fr) Construits cellulaires cultives in vitro, preparation et utilisations
MX9603619A (es) Microparticulas que contienen gas, medios que contienen el ultimo, su uso en diagnosis ultrasonica, tambien como procesos para la produccion de las particulas y los medios.
BR0312197A (pt) Polissacarìdeo supersulfatado de baixo peso molecular
BR0215189A (pt) Combinações de viscoelásticos para uso durante cirurgia
BRPI0608277A2 (pt) método e composição para o reparo de tecidos do coração

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL